TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors
暂无分享，去创建一个
A. Neri | M. Dono | M. Ferrarini | P. Monti | G. Fronza | P. Menichini | G. Cutrona | Z. Salah | F. Fais | G. Tripepi | F. Morabito | M. Gentile | A. Recchia | S. Bossio | M. Hindiyeh | S. Galimberti | L. Morabito | Hamdi Al-Janazreh | Mamdouh Skafi | Moien Atrash | G. De Luca | Alham Mujahed